Vice President, Early Development Program Leads, Hematology, Oncology And Cell Therapy.
CurrentLeader of Global Program Leaders (GPLs)- responsible for progression of development assets through IND to critical development inflections including PoC- leader of 10 GPLs, across 25+ assets in early development pipeline across protein degradation, cell therapy, small and large molecules and ADCs. - member of the Cell Therapy Leadership Team